| C7R | 表記: | 2'-deoxy-5'-O-thiophosphonocytidine | 組成式: | C9 H14 N3 O6 P S | SMILES: | P(S)(O)(OCC1OC(CC1O)N2C=CC(=NC2=O)N)=O | InChi: | InChI=1S/C9H14N3O6PS/c10-7-1-2-12(9(14)11-7)8-3-5(13)6(18-8)4-17-19(15,16)20/h1-2,5-6,8,13H,3-4H2,(H2,10,11,14)(H2,15,16,20)/t5-,6+,8+/m0/s1 | 別名: | 2'-deoxy-5'-O-thiophosphonocytidine (thiophospho connection isoform 1) | 定義日: | 2016-04-28 | 最終更新日: | 2021-03-01 | 公開日: | 2016-06-22 | 識別子(ID): | 2'-deoxy-5'-O-thiophosphonocytidine |
|
| C7S | 表記: | 2'-deoxy-5'-O-thiophosphonocytidine | 組成式: | C9 H14 N3 O6 P S | SMILES: | P(=O)(O)(OCC1C(CC(O1)N2C=CC(=NC2=O)N)O)S | InChi: | InChI=1S/C9H14N3O6PS/c10-7-1-2-12(9(14)11-7)8-3-5(13)6(18-8)4-17-19(15,16)20/h1-2,5-6,8,13H,3-4H2,(H2,10,11,14)(H2,15,16,20)/t5-,6+,8+/m0/s1 | 別名: | 2'-deoxy-5'-O-thiophosphonocytidine (thiophospho connection isoform 2) | 定義日: | 2016-04-28 | 最終更新日: | 2021-03-01 | 公開日: | 2016-06-22 | 識別子(ID): | 2'-deoxy-5'-O-thiophosphonocytidine |
|
| TAX | 表記: | (Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINIUM | 組成式: | C26 H30 N O | SMILES: | O(c1ccc(cc1)C(c2ccccc2)=C(c3ccccc3)CC)CC[NH+](C)C | InChi: | InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/p+1/b26-25+ | 別名: | CIS FORM OF TAMOXIFEN | 定義日: | 2000-08-14 | 最終更新日: | 2021-03-01 | 識別子(ID): | 2-{4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanaminium |
|
| MSC | 表記: | 2,5-DIBENZYLOXY-3,4-DIHYDROXY-HEXANEDIOIC ACID 2-CHLORO-6-FLUORO-BENZYLAMIDE (2-HYDROXY-INDAN-1- YL)-AMIDE | 組成式: | C36 H36 Cl F N2 O7 | SMILES: | Fc1cccc(Cl)c1CNC(=O)C(OCc2ccccc2)C(O)C(O)C(OCc3ccccc3)C(=O)NC5c4ccccc4CC5O | InChi: | InChI=1S/C36H36ClFN2O7/c37-27-16-9-17-28(38)26(27)19-39-35(44)33(46-20-22-10-3-1-4-11-22)31(42)32(43)34(47-21-23-12-5-2-6-13-23)36(45)40-30-25-15-8-7-14-24(25)18-29(30)41/h1-17,29-34,41-43H,18-21H2,(H,39,44)(H,40,45)/t29-,30+,31-,32-,33-,34-/m1/s1 | 別名: | INHIBITOR MSL370 | 定義日: | 1999-10-05 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2R,3R,4R,5R)-2,5-bis(benzyloxy)-N-(2-chloro-6-fluorobenzyl)-3,4-dihydroxy-N'-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide (non-preferred name) |
|
| SH0 | 表記: | 3,3',3'',3'''-[(1R,2S,3S,4S,7S,8S,11S,12S,13S,16S,19S)-3,8,13,17-tetrakis(carboxylatomethyl)-8,13-dimethyl-1,2,3,4,7,8,11,12,13,16,19,20,22,24-tetradecahydroporphyrin-2,7,12,18-tetrayl]tetrapropanoate | 組成式: | C42 H52 N4 O16 | SMILES: | O=C(O)CCC1=C(C2=NC1CC5N=C(C=C4NC(=CC3NC(=C2)C(C)(C3CCC(=O)O)CC(=O)O)C(CC(=O)O)(C)C4CCC(=O)O)C(CC(=O)O)C5CCC(=O)O)CC(=O)O | InChi: | InChI=1S/C42H52N4O16/c1-41(17-39(59)60)23(5-9-35(51)52)29-14-27-21(11-37(55)56)19(3-7-33(47)48)25(43-27)13-26-20(4-8-34(49)50)22(12-38(57)58)28(44-26)15-31-42(2,18-40(61)62)24(6-10-36(53)54)30(46-31)16-32(41)45-29/h14-16,19,21,23-26,30,45-46H,3-13,17-18H2,1-2H3,(H,47,48)(H,49,50)(H,51,52)(H,53,54)(H,55,56)(H,57,58)(H,59,60)(H,61,62)/b29-14-,31-15-,32-16-/t19-,21-,23+,24+,25+,26-,30+,41-,42-/m0/s1 | 別名: | Sirohydrochlorin | 定義日: | 2014-07-09 | 最終更新日: | 2021-03-01 | 公開日: | 2014-07-16 | 識別子(ID): | 3,3',3'',3'''-[(1R,2S,3S,7S,8S,11S,12S,13S,19S)-3,8,13,17-tetrakis(carboxymethyl)-8,13-dimethyl-1,2,3,7,8,11,12,13,19,20-decahydroporphyrin-2,7,12,18-tetrayl]tetrapropanoic acid |
|
| MD2 | 表記: | N,N'-BIS(2,3-BUTADIENYL)-1,4-BUTANE-DIAMINE | 組成式: | C12 H20 N2 | SMILES: | C(=CCNCCCCNC/C=C=C)=C | InChi: | InChI=1S/C12H20N2/c1-3-5-9-13-11-7-8-12-14-10-6-4-2/h5-6,13-14H,1-2,7-12H2 | 別名: | MDL72527 | 定義日: | 1999-08-03 | 最終更新日: | 2021-03-01 | 識別子(ID): | N,N'-dibuta-2,3-dien-1-ylbutane-1,4-diamine |
|
| LXL | 表記: | 1-ethyl-3-[2-methoxy-4-(5-methyl-4-{[(1S)-1-(pyridin-3-yl)butyl]amino}pyrimidin-2-yl)phenyl]urea | 組成式: | C24 H30 N6 O2 | SMILES: | CCNC(=O)Nc1ccc(cc1OC)c2ncc(C)c(n2)NC(CCC)c3cnccc3 | InChi: | InChI=1S/C24H30N6O2/c1-5-8-19(18-9-7-12-25-15-18)28-22-16(3)14-27-23(30-22)17-10-11-20(21(13-17)32-4)29-24(31)26-6-2/h7,9-15,19H,5-6,8H2,1-4H3,(H2,26,29,31)(H,27,28,30)/t19-/m0/s1 | 別名: | Lexibulin | 定義日: | 2015-08-28 | 最終更新日: | 2021-03-01 | 公開日: | 2015-11-04 | 識別子(ID): | 1-ethyl-3-[2-methoxy-4-(5-methyl-4-{[(1S)-1-(pyridin-3-yl)butyl]amino}pyrimidin-2-yl)phenyl]urea |
|
| B11 | 表記: | N-[3-(4-FLUOROPHENOXY)PHENYL]-4-[(2-HYDROXYBENZYL)AMINO]PIPERIDINE-1-SULFONAMIDE | 組成式: | C24 H26 F N3 O4 S | SMILES: | O=S(=O)(Nc2cccc(Oc1ccc(F)cc1)c2)N4CCC(NCc3ccccc3O)CC4 | InChi: | InChI=1S/C24H26FN3O4S/c25-19-8-10-22(11-9-19)32-23-6-3-5-21(16-23)27-33(30,31)28-14-12-20(13-15-28)26-17-18-4-1-2-7-24(18)29/h1-11,16,20,26-27,29H,12-15,17H2 | 別名: | 4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE | 定義日: | 2005-06-27 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-[3-(4-fluorophenoxy)phenyl]-4-[(2-hydroxybenzyl)amino]piperidine-1-sulfonamide |
|
| PA6 | 表記: | (R)-2-(FORMYLOXY)-3-(PHOSPHONOOXY)PROPYL PENTANOATE | 組成式: | C9 H17 O8 P | SMILES: | O=P(O)(OCC(OC=O)COC(=O)CCCC)O | InChi: | InChI=1S/C9H17O8P/c1-2-3-4-9(11)15-5-8(16-7-10)6-17-18(12,13)14/h7-8H,2-6H2,1H3,(H2,12,13,14)/t8-/m1/s1 | 別名: | PHOSPHATIDIC ACID | 定義日: | 2006-11-07 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2R)-2-(formyloxy)-3-(phosphonooxy)propyl pentanoate |
|
| TPV | 表記: | N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE | 組成式: | C31 H33 F3 N2 O5 S | SMILES: | FC(F)(F)c1ccc(nc1)S(=O)(=O)Nc2cccc(c2)C(C=3C(=O)OC(CCC)(CC=3O)CCc4ccccc4)CC | InChi: | InChI=1S/C31H33F3N2O5S/c1-3-16-30(17-15-21-9-6-5-7-10-21)19-26(37)28(29(38)41-30)25(4-2)22-11-8-12-24(18-22)36-42(39,40)27-14-13-23(20-35-27)31(32,33)34/h5-14,18,20,25,36-37H,3-4,15-17,19H2,1-2H3/t25-,30-/m1/s1 | 別名: | TIPRANAVIR | 定義日: | 1999-10-06 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-(3-{(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl}phenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide |
|
| SHH | 表記: | OCTANEDIOIC ACID HYDROXYAMIDE PHENYLAMIDE | 組成式: | C14 H20 N2 O3 | SMILES: | O=C(Nc1ccccc1)CCCCCCC(=O)NO | InChi: | InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18) | 別名: | SAHA | 定義日: | 1999-07-30 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-hydroxy-N'-phenyloctanediamide |
|
| TBH | 表記: | 5-(2-{2-[(TERT-BUTOXY-HYDROXY-METHYL)-AMINO]-1-HYDROXY-3-PHENYL-PROPYLAMINO}-3-HYDROXY-3-PENTYLAMINO-PROPYL)-2-CARBOXYMETHOXY-BENZOIC ACID | 組成式: | C31 H47 N3 O9 | SMILES: | O=C(O)c1cc(ccc1OCC(=O)O)CC(NC(O)C(NC(O)OC(C)(C)C)Cc2ccccc2)C(O)NCCCCC | InChi: | InChI=1S/C31H47N3O9/c1-5-6-10-15-32-27(37)23(18-21-13-14-25(42-19-26(35)36)22(16-21)29(39)40)33-28(38)24(17-20-11-8-7-9-12-20)34-30(41)43-31(2,3)4/h7-9,11-14,16,23-24,27-28,30,32-34,37-38,41H,5-6,10,15,17-19H2,1-4H3,(H,35,36)(H,39,40)/t23-,24-,27+,28-,30-/m0/s1 | 別名: | PNU177836 | 定義日: | 2001-06-26 | 最終更新日: | 2021-03-01 | 識別子(ID): | 5-[(2S,3R)-2-{[(1S,2S)-2-{[(S)-tert-butoxy(hydroxy)methyl]amino}-1-hydroxy-3-phenylpropyl]amino}-3-hydroxy-3-(pentylamino)propyl]-2-(carboxymethoxy)benzoic acid |
|
| MSZ | 表記: | (2S)-(4-chlorophenyl)[3-(trifluoromethyl)phenoxy]ethanoic acid | 組成式: | C15 H10 Cl F3 O3 | SMILES: | Clc1ccc(cc1)C(Oc2cc(ccc2)C(F)(F)F)C(=O)O | InChi: | InChI=1S/C15H10ClF3O3/c16-11-6-4-9(5-7-11)13(14(20)21)22-12-3-1-2-10(8-12)15(17,18)19/h1-8,13H,(H,20,21)/t13-/m0/s1 | 別名: | Metaglidasen (S enantiomer) | 定義日: | 2014-04-09 | 最終更新日: | 2021-03-01 | 公開日: | 2015-02-11 | 識別子(ID): | (2S)-(4-chlorophenyl)[3-(trifluoromethyl)phenoxy]ethanoic acid |
|
| TBL | 表記: | N-[(4-methoxyphenyl)sulfonyl]-D-alanine | 組成式: | C10 H13 N O5 S | SMILES: | O=C(O)C(NS(=O)(=O)c1ccc(OC)cc1)C | InChi: | InChI=1S/C10H13NO5S/c1-7(10(12)13)11-17(14,15)9-5-3-8(16-2)4-6-9/h3-7,11H,1-2H3,(H,12,13)/t7-/m1/s1 | 別名: | (R)-2-(4-methoxyphenylsulfonamido)propanoic acid | 定義日: | 2008-09-18 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-[(4-methoxyphenyl)sulfonyl]-D-alanine |
|
| MT1 | 表記: | N-(4-{[(2,4-DIAMINOPTERIDIN-1-IUM-6-YL)METHYL](METHYL)AMINO}BENZOYL)-L-GLUTAMIC ACID | 組成式: | C20 H23 N8 O5 | SMILES: | O=C(O)C(NC(=O)c1ccc(cc1)N(C)Cc2nc3c(nc2)[nH+]c(nc3N)N)CCC(=O)O | InChi: | InChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/p+1/t13-/m0/s1 | 別名: | METHOTREXATE PROTONATED AT N1 | 定義日: | 2006-10-25 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-[(4-{[(2,4-diaminopteridin-1-ium-6-yl)methyl](methyl)amino}phenyl)carbonyl]-L-glutamic acid |
|
| B1K | 表記: | (2~{R},3~{S},4~{R},5~{R},6~{S})-2-(hydroxymethyl)-6-[5-(4-methoxyphenyl)-1~{H}-1,2,4-triazol-3-yl]oxane-3,4,5-triol | 組成式: | C15 H19 N3 O6 | SMILES: | COc1ccc(cc1)c2[nH]nc(n2)[CH]3O[CH](CO)[CH](O)[CH](O)[CH]3O | InChi: | InChI=1S/C15H19N3O6/c1-23-8-4-2-7(3-5-8)14-16-15(18-17-14)13-12(22)11(21)10(20)9(6-19)24-13/h2-5,9-13,19-22H,6H2,1H3,(H,16,17,18)/t9-,10-,11+,12-,13-/m1/s1 | 別名: | JLH270 | 定義日: | 2017-09-05 | 最終更新日: | 2021-03-01 | 公開日: | 2018-02-28 | 識別子(ID): | (2~{R},3~{S},4~{R},5~{R},6~{S})-2-(hydroxymethyl)-6-[5-(4-methoxyphenyl)-1~{H}-1,2,4-triazol-3-yl]oxane-3,4,5-triol |
|
| R9T | 表記: | (1~{R})-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline | 組成式: | C20 H25 N O4 | SMILES: | COc1ccc(C[CH]2NCCc3cc(OC)c(OC)cc23)cc1OC | InChi: | InChI=1S/C20H25NO4/c1-22-17-6-5-13(10-18(17)23-2)9-16-15-12-20(25-4)19(24-3)11-14(15)7-8-21-16/h5-6,10-12,16,21H,7-9H2,1-4H3/t16-/m1/s1 | 別名: | R-Tetrahydropapaverine | 定義日: | 2016-07-11 | 最終更新日: | 2021-03-01 | 公開日: | 2016-09-07 | 識別子(ID): | (1~{R})-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline |
|
| LY3 | 表記: | 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-4-(2H-TETRAZOL-5-YL)-BUTYRIC ACID | 組成式: | C20 H21 N9 O4 | SMILES: | O=C(O)C(NC(=O)c1ccc(cc1)CCc2cnc3N=C(NC(=O)c23)N)CCc4nnnn4 | InChi: | InChI=1S/C20H21N9O4/c21-20-24-16-15(18(31)25-20)12(9-22-16)6-3-10-1-4-11(5-2-10)17(30)23-13(19(32)33)7-8-14-26-28-29-27-14/h1-2,4-5,9,13H,3,6-8H2,(H,23,30)(H,32,33)(H,26,27,28,29)(H4,21,22,24,25,31)/t13-/m0/s1 | 別名: | LY341770 | 定義日: | 2001-08-24 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2S)-2-[({4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]phenyl}carbonyl)amino]-4-(2H-tetrazol-5-yl)butanoic acid |
|
| TBQ | 表記: | (3~{R})-1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol | 組成式: | C16 H22 Cl N3 O | SMILES: | CC(C)(C)[C](O)(CCc1ccc(Cl)cc1)Cn2cncn2 | InChi: | InChI=1S/C16H22ClN3O/c1-15(2,3)16(21,10-20-12-18-11-19-20)9-8-13-4-6-14(17)7-5-13/h4-7,11-12,21H,8-10H2,1-3H3/t16-/m0/s1 | 別名: | (R)-tebuconazole | 定義日: | 2015-10-20 | 最終更新日: | 2021-03-01 | 公開日: | 2016-02-10 | 識別子(ID): | (3~{R})-1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol |
|
| TBR | 表記: | HEXATANTALUM DODECABROMIDE | 組成式: | Br12 Ta6 | SMILES: | Br|1[Ta]|2|3|4|5|Br[Ta]|6|7|89%10|2|Br[Ta]|%11|%12|%13|%14|1|3|6Br|[Ta]|%15|%16|%17|7|%11(Br|[Ta]|%18|4|%12|%15(Br|%13)(Br|%14)|Br[Ta]|5|8|%16|%18(|Br9)(Br)Br|%17)|Br%10 | InChi: | InChI=1S/12BrH.6Ta/h12*1H | 別名: | DODECABROMOHEXATANTALUM | 定義日: | 1999-11-12 | 最終更新日: | 2021-03-01 |
|
| LYA | 表記: | 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID | 組成式: | C20 H21 N5 O6 | SMILES: | O=C(O)C(NC(=O)c1ccc(cc1)CCc2cnc3NC(=NC(=O)c23)N)CCC(=O)O | InChi: | InChI=1S/C20H21N5O6/c21-20-24-16-15(18(29)25-20)12(9-22-16)6-3-10-1-4-11(5-2-10)17(28)23-13(19(30)31)7-8-14(26)27/h1-2,4-5,9,13H,3,6-8H2,(H,23,28)(H,26,27)(H,30,31)(H4,21,22,24,25,29)/t13-/m0/s1 | 別名: | LY231514 | 定義日: | 2001-08-24 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-({4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]phenyl}carbonyl)-L-glutamic acid |
|
| B1R | 表記: | [(1,2,3,4,5-eta)-cyclopentadienyl][(1,2,3,4,5-eta)-{5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl}cyclopentadienyl]ruthenium | 組成式: | C20 H16 N2 O2 Ru S | SMILES: | O=C1NC2C(SCC2N1)CCCCC(=O)C3%10C%12=C%11C6=C3[Ru]4564789%10C5=C4C9C8=C57 | InChi: | InChI=1S/C15H15N2O2S.C5H.Ru/c18-12(10-5-1-2-6-10)7-3-4-8-13-14-11(9-20-13)16-15(19)17-14 | 別名: | biotinylruthenocene | 定義日: | 2012-12-06 | 最終更新日: | 2021-03-01 | 公開日: | 2013-08-14 | 識別子(ID): | [(1,2,3,4,5-eta)-cyclopentadienyl][(1,2,3,4,5-eta)-{5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl}cyclopentadienyl]ruthenium |
|
| MT9 | 表記: | (3R,4S,5S,7R,9E,11S,12R)-12-ethyl-11-hydroxy-3,5,7,11-tetramethyl-2,8-dioxooxacyclododec-9-en-4-yl 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranoside | 組成式: | C25 H43 N O7 | SMILES: | O=C2OC(CC)C(O)(C=CC(=O)C(C)CC(C(OC1OC(CC(N(C)C)C1O)C)C2C)C)C | InChi: | InChI=1S/C25H43NO7/c1-9-20-25(6,30)11-10-19(27)14(2)12-15(3)22(17(5)23(29)32-20)33-24-21(28)18(26(7)8)13-16(4)31-24/h10-11,14-18,20-22,24,28,30H,9,12-13H2,1-8H3/b11-10+/t14-,15+,16-,17-,18+,20-,21-,22+,24+,25+/m1/s1 | 別名: | methymycin | 定義日: | 2009-04-22 | 最終更新日: | 2021-03-01 | 識別子(ID): | (3R,4S,5S,7R,9E,11S,12R)-12-ethyl-11-hydroxy-3,5,7,11-tetramethyl-2,8-dioxooxacyclododec-9-en-4-yl 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranoside |
|
| C93 | 表記: | 3-(4-hydroxypiperidin-1-yl)benzene-1,2-dicarboxylic acid | 組成式: | C13 H15 N O5 | SMILES: | O=C(O)c1c(c(ccc1)N2CCC(O)CC2)C(=O)O | InChi: | InChI=1S/C13H15NO5/c15-8-4-6-14(7-5-8)10-3-1-2-9(12(16)17)11(10)13(18)19/h1-3,8,15H,4-7H2,(H,16,17)(H,18,19) | 別名: | 3-(4-hydroxypiperidine-1-yl) phthalic acid | 定義日: | 2014-08-19 | 最終更新日: | 2021-03-01 | 公開日: | 2014-10-15 | 識別子(ID): | 3-(4-hydroxypiperidin-1-yl)benzene-1,2-dicarboxylic acid |
|
| MTH | 表記: | 2-(4-AMINO-PYRROLO[2,3-D]PYRIMIDIN-7-YL)-5-METHYLSULFANYLMETHYL-TETRAHYDRO-FURAN-3,4-DIOL | 組成式: | C12 H16 N4 O3 S | SMILES: | S(C)CC3OC(n2ccc1c(ncnc12)N)C(O)C3O | InChi: | InChI=1S/C12H16N4O3S/c1-20-4-7-8(17)9(18)12(19-7)16-3-2-6-10(13)14-5-15-11(6)16/h2-3,5,7-9,12,17-18H,4H2,1H3,(H2,13,14,15)/t7-,8-,9-,12-/m1/s1 | 別名: | 5'-DEOXY-5'-(METHYLTHIO)-TUBERCIDIN | 定義日: | 2002-12-12 | 最終更新日: | 2021-03-01 | 識別子(ID): | 7-(5-S-methyl-5-thio-beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
|